Entering text into the input field will update the search result below

Blueprint Medicines Corporation's (BPMC) CEO Jeff Albers on Q1 2020 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Blueprint Medicines Corporation (NASDAQ:BPMC) Q1 2020 Earnings Conference Call May 6, 2020 8:30 AM ET

Company Participants

Kristin Hodous - Senior Manager, IR

Jeff Albers - CEO

Christy Rossi - Chief Commercial Officer

Mike Landsittel - CFO

Andy Boral - Chief Medical Officer

Conference Call Participants

Dane Leone - Raymond James

Joseph Thome - Cowen and Company

Konstantinos Aprilakis - Deutsche Bank

Reni Benjamin - JMP Securities

Eun Yang - Jefferies

Peter Lawson - Barclays


Ladies and gentlemen, thank you for standing by. And welcome to the Blueprint Medicines Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]

And I would now like to hand the conference over to your speaker today, Kristin Hodous of Blueprint Medicines. Thank you, and please go ahead, ma'am.

Kristin Hodous

Thank you, Operator. Good morning, everyone. This is Kristin Hodous of Blueprint Medicines. And welcome to Blueprint Medicines first quarter 2020 financial and operating results conference call.

This morning, we issued a press release, which outlines the topics that we plan to discuss today. You can access the press release, as well as the slides that we'll be reviewing today by going to the Investors section of our website at www.blueprintmedicines.com.

Today, on our call, Jeff Albers, our Chief Executive Officer, will discuss Blueprint Medicines first quarter 2020 business highlights; Christy Rossi, our Chief Commercial Officer, will provide an update on the initial launch of AYVAKIT for the treatment of PDGFRA exon 18 mutant GIST; and Mike Landsittel, our Chief Financial Officer, will review our first quarter 2020 financial results; Dr. Andy Boral, our Chief Medical Officer is also during the call and will be available for Q&A.

Before we get started, I would like to remind everyone that

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About BPMC

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on BPMC

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.